Xiaofei Hu

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials

Emma Guttman‐Yassky, Henrique D. Teixeira, Eric L. Simpson et al. · The Lancet · 2021 · 543 citations

Life Sciences, Dermatology, Pharmacotherapy +13

Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial

Kristian Reich, Henrique D. Teixeira, Marjolein de Bruin‐Weller et al. · The Lancet · 2021 · 389 citations

Medicine, Dermatology, Pediatrics +16

Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis

Eric L. Simpson, Kim Papp, Andrew Blauvelt et al. · JAMA Dermatology · 2022 · 204 citations · Full text

Medicine, Dermatology, Pharmacotherapy +12

Anti-atherosclerotic potential of baicalin mediated by promoting cholesterol efflux from macrophages via the PPARγ-LXRα-ABCA1/ABCG1 pathway

Xinwei He, Dan Yu, Weiling Li et al. · Biomedicine & Pharmacotherapy · 2016 · 104 citations

Life Sciences, Medicinal Chemistry, Pharmacology +14

Litter manipulation effects on microbial communities and enzymatic activities vary with soil depth in a subtropical Chinese fir plantation

Ren Liu, Yang Zhang, Xiaofei Hu et al. · Forest Ecology and Management · 2020 · 83 citations

Agriculture, Plant Sciences, Soil Sciences +17